Triglycerides
Elevated lipid levels may be tied to cardiac damage in adolescents, young adults
Elevated lipid levels were associated with worsening structural and functional cardiac damage in adolescents and young adults, though in the case of LDL, the relationship was partially mediated by elevated BP and fat mass, data show.
Engaging in light physical activity reduces cholesterol, improves lipids for adolescents
Adolescents and young adults who partake in more light physical activity have lower cholesterol levels, according to a study published in The Journal of Clinical Endocrinology & Metabolism.
VIDEO: Monitor weight, cardiometabolic factors for adults receiving gender-confirming HT
DALLAS — In this Healio video exclusive, Michael S. Irwig, MD, discusses how gender-confirming hormone therapy may affect obesity and cardiometabolic health.
High triglyceride levels exacerbate severity, complications of acute pancreatitis in NAFLD
Elevated serum triglyceride levels were associated with severity of acute pancreatitis and risk for related complications, including organ failure, among patients with nonalcoholic fatty liver disease, according to data.
Remnant cholesterol accumulation tied to risk for atherosclerosis
Data show that higher cumulative remnant cholesterol and greater remnant cholesterol variability are each associated with elevated risk for atherosclerosis, independent of LDL, triglycerides level and other traditional CV risk factors.
Higher levels of diglycerides, triglycerides adversely associated with glaucoma
Higher levels of diglycerides and triglycerides were found to be associated with increased risk for primary open-angle glaucoma in a study.
VIDEO: The latest in lipid-lowering therapy at NLA with Christie M. Ballantyne
In this Healio | Cardiology Today video exclusive, Christie M. Ballantyne, MD, FACC, FACP, FAHA, FNLA, provided a review of the NLA Scientific Session opening session, “The Latest in Lipid Lowering Therapy – It's Not Just a Phase.”
Semaglutide may reduce risk for atherosclerotic CVD among adults with obesity
Adults with obesity who used semaglutide for weight loss reduced their 10-year risk for atherosclerotic cardiovascular disease, according to findings presented at the European Congress on Obesity.
New dietary recommendations, dyslipidemia guidelines and more to be featured at NLA 2023
The National Lipid Association Scientific Sessions will be held today to Sunday and will spotlight statements on nutrition in adults with dyslipidemia, include sessions on the integration of lipid guidelines in clinical practice and more.
Semaglutide linked to significant weight loss in adults with obesity in real-world study
Adults with overweight or obesity receiving semaglutide lost 13.4% of their body weight at 1 year, according to findings from a real-world study presented at the European Congress on Obesity.